Zobrazeno 1 - 10
of 1 218
pro vyhledávání: '"Treatment Burden"'
Publikováno v:
Clinical Ophthalmology, Vol Volume 18, Pp 3645-3655 (2024)
Hanna Heloterä,1,2 Anna-Mari Viita,1 Juha Laine1,3 1Roche Oy, Espoo, Finland; 2Department of Ophthalmology, University of Eastern Finland, Kuopio, Finland; 3InFLAMES Flagship, University of Turku, Turku, FinlandCorrespondence: Juha Laine, Roche Oy,
Externí odkaz:
https://doaj.org/article/258ddb1e06ee44a99391f51f96597bf7
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1507-1525 (2024)
Abstract The number of disease-modifying therapies (DMTs) approved for the treatment of multiple sclerosis (MS) has greatly increased in recent decades, leading to higher treatment complexity. DMTs can differ in mode and frequency of administration,
Externí odkaz:
https://doaj.org/article/91d4d5f84d1c472cb202aba7b8c27a05
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-22 (2024)
Abstract Background People living with multimorbidity experience increased treatment burden, which can result in poor health outcomes. Despite previous efforts to grasp the concept of treatment burden, the treatment burden of people living with multi
Externí odkaz:
https://doaj.org/article/462eb1acd1c34695a295d19152c5119d
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 17, Pp 2009-2021 (2024)
Zhihui Jia,1 Zimin Niu,1 Jia Ji Wang,2,3 Jose Hernandez,4,5 Yu Ting Li,6,7 Harry HX Wang1,8,9 1School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China; 2School of Public Health, Guangzhou Medical University, Guangzhou
Externí odkaz:
https://doaj.org/article/fb0df45ef1014bcb891a63bc698ba09e
Autor:
Zijun Xu, Dexing Zhang, Yang Zhao, Arpita Ghosh, David Peiris, Yiqi Li, Samuel Yeung Shan Wong
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background Validated and comprehensive tools to measure treatment burden are needed for healthcare professionals to understand the treatment burden of patients in China. The study aimed to translate and validate the Chinese version of Patien
Externí odkaz:
https://doaj.org/article/758795317f0f4235a433e80afb65eae9
Autor:
Kai Lin, Mi Yao, Xinxin Ji, Rouyan Li, Lesley Andrew, Jacques Oosthuizen, Moira Sim, Yongsong Chen
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Measuring treatment burden is important for the effective management of Type 2 Diabetes Mellitus (T2DM) care. The purpose of this systematic review was to identify the most robust approach for measuring treatment burden in people
Externí odkaz:
https://doaj.org/article/8c922aae5eae4458a420ac01edc9a311
Autor:
MIlan Nedeljkovic, Miroslav Mihajlovic, Nebojsa Mujovic, Gregory Y.H. Lip, Tatjana S. Potpara
Publikováno v:
Archives of Medical Science, Vol 20, Iss 3, Pp 1006-1010 (2024)
Introduction Patient-reported treatment burden (TBN) refers to the patient’s time and effort invested in the management of their chronic health conditions. The aim of this research was to explore TBN in patients with coronary artery disease (CAD).
Externí odkaz:
https://doaj.org/article/f837d8eb6c3d485a8afc3c120cc0052c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shane P. Cross, Mario Alvarez-Jimenez
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
Mental health disorders affect a substantial portion of the global population. Despite preferences for psychotherapy, access remains limited due to various barriers. Digital mental health interventions (DMHIs) have emerged to increase accessibility,
Externí odkaz:
https://doaj.org/article/3296ec289dfc4ab0bc410e0bf6cc7891
Autor:
Bülent Zülfikar, Johnny Mahlangu, Salim Mohamed Nekkal, Cecil Ross, Noppacharn Uaprasert, Jerzy Windyga, Carmen Escuriola Ettingshausen, Bettina Ploder, Aurelia Lelli, Hanna T. Gazda
Publikováno v:
TH Open, Vol 08, Iss 03, Pp e273-e282 (2024)
Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion rates wer
Externí odkaz:
https://doaj.org/article/d6aef7dc90ac43e488c3d85c23242dd4